Bio Path Holdings Inc
OTC:BPTH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bio Path Holdings Inc
OTC:BPTH
|
US |
|
argenx SE
XBRU:ARGX
|
NL |
|
V
|
Verisk Analytics Inc
BMV:VRSK
|
US |
|
Inventiva SA
F:6IV
|
FR |
|
E
|
Eurotech Ltd
OTC:EUOT
|
US |
|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
US |
|
Gold Resource Corp
LSE:0IYS
|
US |
|
P
|
Profithol SA
MAD:SPH
|
ES |
|
N
|
National Bank of Canada
OTC:NTIOF
|
CA |
|
P
|
Plaza Wires Ltd
NSE:PLAZACABLE
|
IN |
|
Conrad Asia Energy Ltd
F:3MD
|
ID |
|
W
|
Winpak Ltd
TSX:WPK
|
CA |
|
T
|
Thai Group Holdings PCL
SET:TGH
|
TH |
|
C
|
Cardinal Health Inc
DUS:CLH
|
US |
|
Soiken Holdings Inc
TSE:2385
|
JP |
|
E
|
Eisen und Huettenwerke AG
F:EIS
|
DE |
|
V
|
Victek Co Ltd
KOSDAQ:065450
|
KR |
|
Artgo Holdings Ltd
HKEX:3313
|
CN |
|
Hims & Hers Health Inc
BMV:HIMS
|
US |
|
Walmart Inc
NASDAQ:WMT
|
US |
|
J
|
JR Holding Alternatywna Spolka Inwestycyjna SA
WSE:JRH
|
PL |
|
M
|
Monogram Orthopaedics Inc
NASDAQ:MGRM
|
US |
|
F
|
FirstEnergy Corp
F:FE7
|
US |
Bankruptcy Probability
Bio Path Holdings Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Bio Path Holdings Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Bio Path Holdings Inc
OTC:BPTH
|
1.7m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
450.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
206.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
179.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
54.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Bio Path Holdings Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Bio Path Holdings Inc has total debt of 511k USD. This includes both short-term (511k USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
